Dynamo: a Tailored Lifestyle Promotion Intervention Among Pediatric Patients With Cardiometabolic Risk Factors

ConditionObese
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6-18
SponsorSt. Justine's Hospital

About this trial

The Dyn@mo lifestyle intervention (CHU Sainte-Justine, Quebec, Canada) targets children and adolescents aged 6 to 17 years old with cardiometabolic risk factors, such as obesity, hypertension, disorders in glucose regulation or dyslipidemia. Its primary goal is to promote physical activity and reduce sedentary time to improve childrens' cardiometabolic profile. To do so, the intervention relies on gathering data on mobility and physical activity using wearable sensors. These data provide a detailed picture of real-life conditions and physical activity levels, improving the health care professional's ability to tailor counseling. The investigators are presently in the implementation phase of this intervention.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

children ages 6 to 18 years of age with a BMI > 95th percentile for age and sex

Disqualifiers

children with a physical or psychological condition that would impair their ability to participate in physical activity

Trial design

Design model

Parallel

Treatments tested in this trial

  • Sensor based PA intervention

    Behavioral

    Children will be equipped with a heart rate monitor, a GPS receiver and an accelerometer for collection of heart rate, mobility and physical activity free-living data during a 7-day period. This will provide a 'spatio-behavioural diagnosis' using a map-based interactive web application. This data will be used to developed a tailored plan to promote physical activity in the child's every day environment.

  • Traditional PA counseling

    Behavioral

    Children will be encouraged to enhance their physical activity levels using traditional behavioral approaches.

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: Sensor based PA interventionExperimental treatment 1 intervention
Group B: Traditional PA counselingOther 1 intervention

Trial outcomes

Primary outcomes

1

Change in physical activity levels

Physical activity will be measured using accelerometry and we will use time spent in moderate to vigorous physical activity as our primary measure of PA

Time frame
Baseline and 1 year

Secondary outcomes

1

Change in blood pressure

Both systolic and diastolic blood pressure will be measured

Time frame
Baseline and 1 year
2

Change in glucose homeostasis

Both fasting blood glucose, and glucose 2hr post load (oral glucose tolerance test) will be measured

Time frame
Baseline and 1 year
3

Change in lipid status

LDL, HDL, triglycerides and total cholesterol will be measured at baseline and after 1 year of follow-up

Time frame
Baseline and 1 year
4

Change in body mass index

We will measure height and weight at baseline and at 1 year of follow-up and calculate differences in body mass index over the 1 year period

Time frame
Baseline and 1 year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.